Kunimoto Ichikawa Selected Research

Kunimoto Ichikawa Research Topics

Disease

5	Neoplasms (Cancer) 01/2015 - 01/2014
3	Fever (Fevers) 11/2016 - 05/2011
3	Multiple Myeloma 01/2015 - 01/2012
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2014 - 01/2011
2	Fibrosis (Cirrhosis) 11/2015 - 01/2014
2	Lymphoma (Lymphomas) 01/2014 - 01/2011
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 11/2016
1	Leukemia 11/2016
1	Multi-centric Castleman's Disease 11/2015
1	Edema (Dropsy) 11/2015
1	Lymphomatoid Granulomatosis (Granulomatosis, Lymphomatoid) 07/2015
1	Plasmacytoma 01/2015
1	Rheumatoid Arthritis 01/2015
1	Virus Diseases (Viral Diseases) 01/2015
1	Disease Progression 01/2015
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2014
1	Hemolysis 10/2014
1	Autoimmune Diseases (Autoimmune Disease) 01/2014
1	Sarcoma (Soft Tissue Sarcoma) 01/2014
1	Trisomy 18 Syndrome 01/2014
1	Trisomy (Trisomies) 01/2014
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2014
1	Inflammation (Inflammations) 01/2014
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2012
1	Pneumonia (Pneumonitis) 01/2012
1	Malignant Pleural Effusion 01/2012
1	Ascites 01/2012
1	Plasma Cell Leukemia 01/2012
1	Hemorrhage 05/2011
1	Enterocolitis 05/2011
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2011
1	Diarrhea 05/2011
1	Colitis 05/2011
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2011
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2011

Drug/Important Bio-Agent (IBA)

3	Dexamethasone (Maxidex)FDA LinkGeneric 07/2015 - 01/2012
3	Bortezomib (Velcade)FDA Link 01/2015 - 01/2012
2	Prednisolone (Predate)FDA LinkGeneric 11/2015 - 01/2012
2	Rituximab (Mabthera)FDA Link 07/2015 - 10/2014
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2015 - 01/2012
2	CytokinesIBA 01/2015 - 01/2014
2	Immunoglobulin G (IgG)IBA 01/2015 - 01/2014
2	Proteins (Proteins, Gene)FDA Link 01/2015 - 01/2014
2	Lenalidomide (CC 5013)FDA Link 01/2015 - 01/2012
2	AntigensIBA 01/2014 - 05/2011
2	Imatinib Mesylate (Gleevec)FDA Link 10/2012 - 05/2011
1	formycin diphosphate (FDP)IBA 11/2016
1	Fibrinogen (Factor I)FDA Link 11/2016
1	FibrinIBA 11/2016
1	SteroidsIBA 11/2015
1	Reticulin (Reticular Fiber)IBA 11/2015
1	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2015
1	Etoposide (VP 16)FDA LinkGeneric 07/2015
1	Methotrexate (Mexate)FDA LinkGeneric 01/2015
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2015
1	InterferonsIBA 01/2015
1	Interleukin-2 (IL2)IBA 01/2015
1	RNA (Ribonucleic Acid)IBA 01/2015
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2015
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2015
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015
1	Azacitidine (5 Azacytidine)FDA Link 10/2014
1	Capsules (Microcapsules)IBA 01/2014
1	Peptides (Polypeptides)IBA 01/2014
1	Platelet-Derived Growth FactorIBA 01/2014
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2014
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2014
1	Hematoxylin (Haematoxylon)IBA 01/2014
1	Vincristine (Oncovin)FDA LinkGeneric 01/2012
1	Vindesine (Vindesin)IBA 01/2012
1	ranimustineIBA 01/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2012
1	Melphalan (Alkeran)FDA LinkGeneric 01/2012
1	Prednisone (Sone)FDA LinkGeneric 01/2012
1	Thalidomide (Thalomid)FDA Link 01/2012
1	Dasatinib (BMS 354825)FDA Link 05/2011
1	Ganciclovir (Cytovene)FDA LinkGeneric 05/2011
1	nilotinib FDA Link 05/2011
1	Immunoglobulin M (IgM)IBA 01/2011
1	CyclinsIBA 01/2011

Therapy/Procedure

5	Therapeutics 11/2015 - 05/2011
3	Drug Therapy (Chemotherapy) 01/2015 - 05/2011
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2015